BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 26683155)

  • 1. Negative regulation of TLR signaling in myeloid cells--implications for autoimmune diseases.
    Hamerman JA; Pottle J; Ni M; He Y; Zhang ZY; Buckner JH
    Immunol Rev; 2016 Jan; 269(1):212-27. PubMed ID: 26683155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FcγRIIa cross-talk with TLRs, IL-1R, and IFNγR selectively modulates cytokine production in human myeloid cells.
    Vogelpoel LT; Hansen IS; Visser MW; Nagelkerke SQ; Kuijpers TW; Kapsenberg ML; de Jong EC; den Dunnen J
    Immunobiology; 2015 Feb; 220(2):193-9. PubMed ID: 25108563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of plasmacytoid dendritic cells response in inflammation and autoimmunity.
    Ah Kioon MD; Laurent P; Chaudhary V; Du Y; Crow MK; Barrat FJ
    Immunol Rev; 2024 May; 323(1):241-256. PubMed ID: 38553621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTPN22 Variant R620W Is Associated With Reduced Toll-like Receptor 7-Induced Type I Interferon in Systemic Lupus Erythematosus.
    Wang Y; Ewart D; Crabtree JN; Yamamoto A; Baechler EC; Fazeli P; Peterson EJ
    Arthritis Rheumatol; 2015 Sep; 67(9):2403-14. PubMed ID: 26018863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone methyltransferase Ash1l suppresses interleukin-6 production and inflammatory autoimmune diseases by inducing the ubiquitin-editing enzyme A20.
    Xia M; Liu J; Wu X; Liu S; Li G; Han C; Song L; Li Z; Wang Q; Wang J; Xu T; Cao X
    Immunity; 2013 Sep; 39(3):470-81. PubMed ID: 24012418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology.
    Vereecke L; Beyaert R; van Loo G
    Trends Immunol; 2009 Aug; 30(8):383-91. PubMed ID: 19643665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A20/Tumor Necrosis Factor α-Induced Protein 3 in Immune Cells Controls Development of Autoinflammation and Autoimmunity: Lessons from Mouse Models.
    Das T; Chen Z; Hendriks RW; Kool M
    Front Immunol; 2018; 9():104. PubMed ID: 29515565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-Like Receptor Pathways in Autoimmune Diseases.
    Chen JQ; Szodoray P; Zeher M
    Clin Rev Allergy Immunol; 2016 Feb; 50(1):1-17. PubMed ID: 25687121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone lysine methyltransferase Ezh1 promotes TLR-triggered inflammatory cytokine production by suppressing Tollip.
    Liu Y; Zhang Q; Ding Y; Li X; Zhao D; Zhao K; Guo Z; Cao X
    J Immunol; 2015 Mar; 194(6):2838-46. PubMed ID: 25687760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphatase PTP1B negatively regulates MyD88- and TRIF-dependent proinflammatory cytokine and type I interferon production in TLR-triggered macrophages.
    Xu H; An H; Hou J; Han C; Wang P; Yu Y; Cao X
    Mol Immunol; 2008 Aug; 45(13):3545-52. PubMed ID: 18571728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The autoimmunity-associated gene PTPN22 potentiates toll-like receptor-driven, type 1 interferon-dependent immunity.
    Wang Y; Shaked I; Stanford SM; Zhou W; Curtsinger JM; Mikulski Z; Shaheen ZR; Cheng G; Sawatzke K; Campbell AM; Auger JL; Bilgic H; Shoyama FM; Schmeling DO; Balfour HH; Hasegawa K; Chan AC; Corbett JA; Binstadt BA; Mescher MF; Ley K; Bottini N; Peterson EJ
    Immunity; 2013 Jul; 39(1):111-22. PubMed ID: 23871208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The autoimmune disease-associated PTPN22 variant promotes calpain-mediated Lyp/Pep degradation associated with lymphocyte and dendritic cell hyperresponsiveness.
    Zhang J; Zahir N; Jiang Q; Miliotis H; Heyraud S; Meng X; Dong B; Xie G; Qiu F; Hao Z; McCulloch CA; Keystone EC; Peterson AC; Siminovitch KA
    Nat Genet; 2011 Aug; 43(9):902-7. PubMed ID: 21841778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FcγR-TLR Cross-Talk Enhances TNF Production by Human Monocyte-Derived DCs via IRF5-Dependent Gene Transcription and Glycolytic Reprogramming.
    Hoepel W; Newling M; Vogelpoel LTC; Sritharan L; Hansen IS; Kapsenberg ML; Baeten DLP; Everts B; den Dunnen J
    Front Immunol; 2019; 10():739. PubMed ID: 31024565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orphan Nuclear Receptor ERRα Controls Macrophage Metabolic Signaling and A20 Expression to Negatively Regulate TLR-Induced Inflammation.
    Yuk JM; Kim TS; Kim SY; Lee HM; Han J; Dufour CR; Kim JK; Jin HS; Yang CS; Park KS; Lee CH; Kim JM; Kweon GR; Choi HS; Vanacker JM; Moore DD; Giguère V; Jo EK
    Immunity; 2015 Jul; 43(1):80-91. PubMed ID: 26200012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined CpG and poly I:C stimulation of monocytes results in unique signaling activation not observed with the individual ligands.
    Arsenault RJ; Kogut MH; He H
    Cell Signal; 2013 Nov; 25(11):2246-54. PubMed ID: 23876795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphoid-specific tyrosine phosphatase (Lyp): a potential drug target for treatment of autoimmune diseases.
    Du J; Qiao Y; Sun L; Wang X
    Curr Drug Targets; 2014 Mar; 15(3):335-46. PubMed ID: 24188455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein tyrosine phosphatase PTPN22 in human autoimmunity.
    Vang T; Miletic AV; Bottini N; Mustelin T
    Autoimmunity; 2007 Sep; 40(6):453-61. PubMed ID: 17729039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of A20 in autoimmune diseases.
    Zhang M; Peng LL; Wang Y; Wang JS; Liu J; Liu MM; Hu J; Song B; Yang HB
    Immunol Res; 2016 Apr; 64(2):337-44. PubMed ID: 26135958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B cell autophagy mediates TLR7-dependent autoimmunity and inflammation.
    Weindel CG; Richey LJ; Bolland S; Mehta AJ; Kearney JF; Huber BT
    Autophagy; 2015; 11(7):1010-24. PubMed ID: 26120731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new benzenediamine derivative modulates Toll-like receptors-induced myeloid dendritic cells activation and ameliorates lupus-like syndrome in MRLlpr/lpr mice.
    Gao S; Gong Y; Ji J; Yuan L; Han L; Guo Y; Fan X; Hou Y; Hua C
    Eur J Pharmacol; 2017 May; 803():94-102. PubMed ID: 28342978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.